NIPH
REGN icon

NN Investment Partners Holdings’s Regeneron Pharmaceuticals REGN Stock Holding History

NN Investment Partners Holdings’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$29.5M Sell
42,182
-46,271
-52% -$29.3M 0.16% 124
2021
Q4 		$55.9M Buy
88,453
+25,594
+41% +$15.7M 0.28% 63
2021
Q3 		$38M Buy
62,859
+6,945
+12% +$4.31M 0.21% 87
2021
Q2 		$31.2M Sell
55,914
-8,034
-13% -$4.07M 0.17% 112
2021
Q1 		$30.3M Sell
63,948
-5,058
-7% -$2.46M 0.18% 109
2020
Q4 		$33.3M Buy
69,006
+55,403
+407% +$29.9M 0.2% 89
2020
Q3 		$7.62M Sell
13,603
-2,016
-13% -$1.22M 0.05% 283
2020
Q2 		$9.74M Sell
15,619
-26,475
-63% -$15M 0.07% 231
2020
Q1 		$20.6M Sell
42,094
-72,492
-63% -$29.9M 0.17% 114
2019
Q4 		$43M Buy
114,586
+27,760
+32% +$9.34M 0.29% 74
2019
Q3 		$24.1M Buy
86,826
+79,347
+1,061% +$23.5M 0.19% 123
2019
Q2 		$2.34M Sell
7,479
-87,162
-92% -$29M 0.02% 441
2019
Q1 		$38.9M Buy
94,641
+36,077
+62% +$14.9M 0.3% 83
2018
Q4 		$21.9M Buy
+58,564
New +$21.4M 0.19% 119
2018
Q2 		– Sell
-447
Closed -$154K – 654
2018
Q1 		$154K Buy
447
+45
+11% +$15.7K ﹤0.01% 623
2017
Q4 		$151K Sell
402
-1,002
-71% -$406K ﹤0.01% 609
2017
Q3 		$628K Buy
1,404
+905
+181% +$431K ﹤0.01% 605
2017
Q2 		$245K Hold
499
– – ﹤0.01% 705
2017
Q1 		$193K Hold
499
– – ﹤0.01% 631
2016
Q4 		$183K Hold
499
– – ﹤0.01% 689
2016
Q3 		$201K Hold
499
– – ﹤0.01% 679
2016
Q2 		$174K Sell
499
-3,600
-88% -$1.39M ﹤0.01% 652
2016
Q1 		$1.48M Buy
+4,099
New +$1.69M 0.01% 390

Other funds holding REGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

NN Investment Partners Holdings's REGN Position: Q1 2022 in Review

NN Investment Partners Holdings reduced its Regeneron Pharmaceuticals (REGN) stake by 52% in Q1 2022, selling an estimated $29.3M and leaving 42,182 shares worth $29.5M. The position accounts for 0.16% of the portfolio, ranked #124.

NN Investment Partners Holdings first reported a position in REGN in Q1 2016 and has held it in 23 quarters since. The position peaked at $55.9M in Q4 2021. 1,095 funds tracked by Wall St. Rank hold REGN as of Q1 2022.

  • NN Investment Partners Holdings held 42,182 shares of Regeneron Pharmaceuticals worth $29.5M as of Q1 2022.
  • NN Investment Partners Holdings sold 46,271 Regeneron Pharmaceuticals shares in Q1 2022, an estimated $29.3M.
  • Regeneron Pharmaceuticals made up 0.16% of NN Investment Partners Holdings's portfolio in Q1 2022, its #124 holding.
  • NN Investment Partners Holdings first reported a position in Regeneron Pharmaceuticals in Q1 2016 and has held it in 23 quarters since.
  • NN Investment Partners Holdings's Regeneron Pharmaceuticals position peaked at $55.9M in Q4 2021.
  • 1,095 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q1 2022.

Based on NN Investment Partners Holdings's 13F filing for Q1 2022, filed 11 May 2022.